Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats

被引:0
|
作者
Marques, M
Millás, I
Jiménez, A
García-Colis, E
Rodriguez-Feo, JA
Velasco, S
Barrientos, A
Casado, S
López-Farré, A
机构
[1] Fdn Jimenez Diaz, Cardiovasc & Hypertens Res Lab, E-28040 Madrid, Spain
[2] Hosp Clin U San Carlos, Dept Nephrol, Madrid, Spain
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Low-level lead exposure is a known cause of hypertension that has been associated with increased reactive oxygen species activity and endothelial-dependent vasorelaxation impairment. The effect of lead exposure on the vascular nitric oxide (NO)/cyclic guanocine monophosphate (cGMP) system was analyzed. Wistar rats were exposed to 5 ppm lead acetate in the drinking water during 30 d. Mean arterial BP increased significantly in the lead-treated rats. Relaxation to both acetylcholine and sodium nitroprusside (SNP) was reduced in lead-treated rats: however. the vascular wall of lead-administered rats showed an increased expression of endothelial NO synthase. The expression of both subunits (alpha (1) and beta (1)) of soluble guanylate cyclase (sGC) and the cGMP accumulated in the vascular wall were decreased in lead-treated rats. Cotreatment of lead with vitamin C (3 mmol/L) prevented the increase on mean arterial BP. improved the relaxation to both acetylcholine and sodium nitroprusside, and restored the normal expression of endothelial NO synthase and sGC proteins in the vascular wall. In conclusion, lead exposure altered both the endothelium-dependent and -independent relaxing response and induced a reduced expression of sGC in the vascular wall. These effects were abrogated with the antioxidant vitamin C. which suggests the involvement of reactive oxygen species in the regulation of the NO/cGMP relaxing system in the vascular wall of lead-treated rats.
引用
收藏
页码:2594 / 2600
页数:7
相关论文
共 50 条
  • [21] Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet-fed rabbits
    Tawa, Masashi
    Nakano, Katsuya
    Yamashita, Yuka
    He, Qiang
    Masuoka, Takayoshi
    Okamura, Tomio
    Ishibashi, Takaharu
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (04):
  • [22] Stimulation of Soluble Guanylate Cyclase Prevents Cigarette Smoke-induced Pulmonary Hypertension and Emphysema
    Weissmann, Norbert
    Lobo, Borja
    Pichl, Alexandra
    Parajuli, Nirmal
    Seimetz, Michael
    Puig-Pey, Raquel
    Ferrer, Elisabet
    Peinado, Victor I.
    Dominguez-Fandos, David
    Fysikopoulos, Athanasios
    Stasch, Johannes-Peter
    Ghofrani, Hossein A.
    Coll-Bonfill, Nuria
    Frey, Reiner
    Schermuly, Ralph T.
    Garcia-Lucio, Jessica
    Blanco, Isabel
    Bednorz, Mariola
    Tura-Ceide, Olga
    Tadele, Elsa
    Brandes, Ralf P.
    Grimminger, Jan
    Klepetko, Walter
    Jaksch, Peter
    Rodriguez-Roisin, Robert
    Seeger, Werner
    Grimminger, Friedrich
    Barbera, Joan A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (11) : 1359 - 1373
  • [23] LEAD-INDUCED INHIBITION OF BRAIN ADENYL-CYCLASE
    NATHANSON, JA
    BLOOM, FE
    NATURE, 1975, 255 (5507) : 419 - 420
  • [24] The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
    Benza, Raymond L.
    Gruenig, Ekkehard
    Sandner, Peter
    Stasch, Johannes -Peter
    Simonneau, Gerald
    EUROPEAN RESPIRATORY REVIEW, 2024, 33 (171):
  • [25] Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy
    Ghofrani, H. A.
    Grimminger, F.
    EUROPEAN RESPIRATORY REVIEW, 2009, 18 (111): : 35 - 41
  • [26] Pharmacological activation of soluble guanylate cyclase improves vascular graft function
    Veres, Gabor
    Bai, Yang
    Stark, Klara Aliz
    Schmidt, Harald
    Radovits, Tamas
    Loganathan, Sivakkanan
    Korkmaz-Icoez, Sevil
    Szabo, Gabor
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021, 32 (05) : 803 - 811
  • [27] A novel approach for the treatment of hypertension with the soluble guanylate cyclase stimulating drug
    Chrysant, Steven G.
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 635 - 640
  • [28] Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension
    Oka, Masahiko
    Karoor, Vijaya
    Homma, Noriyuki
    Nagaoka, Tetsutaro
    Sakao, Eiko
    Golembeski, Scott M.
    Limbird, Jennifer
    Imamura, Masatoshi
    Gebb, Sarah A.
    Fagan, Karen A.
    McMurtry, Ivan F.
    CARDIOVASCULAR RESEARCH, 2007, 74 (03) : 377 - 387
  • [29] Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
    Belik, Jaques
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 971 - 979
  • [30] Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats
    Masuyama, Hiroyuki
    Tsuruda, Toshihiro
    Kato, Johji
    Imamura, Takuroh
    Asada, Yujiro
    Stasch, Johannes-Peter
    Kitamura, Kazuo
    Eto, Tanenao
    HYPERTENSION, 2006, 48 (05) : 972 - 978